---
title: Improve walking while dual tasking
nct_id: NCT06416722
phase: NA
status: RECRUITING
sponsor: Fenerbahce University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06416722"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06416722"
last_fetched: "2026-05-10T14:06:55.745Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking while dual tasking

**Goal (in five words):** Improve walking while dual tasking

**Official Title:** Multidimensional Evaluation of the Effectiveness of Telerehabilitation-Based Dual-Task Training in Parkinson's Patients

**Trial ID:** [NCT06416722](https://clinicaltrials.gov/study/NCT06416722)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Fenerbahce University
- **Target Enrollment:** 30 participants
- **Start Date:** 2024-09-01
- **Completion Date:** 2025-12-01
- **Conditions:** Parkinson Disease
- **Interventions:** Cognitive-Motor Dual Task Activities, Motor-Motor Dual Task Activities, Cognitive-Motor & Motor-Motor Dual Task Activities
- **Intervention Types:** OTHER

## Summary For Families

The goal is to help people with Parkinson's improve walking, balance, and the ability to do a second task at the same time, like talking or carrying something, so everyday multitasking causes fewer stumbles, freezes, and balance problems. The approach uses telerehabilitation to guide dual-task exercises that pair walking with cognitive tasks or a second motor task, training the brain and body to coordinate attention and movement better; sessions are done remotely via smartphone or computer and are meant to complement your usual Parkinson's medications rather than replace them. The study is enrolling 30 people aged 30 to 75 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk independently, are in their "On" period, have had stable medication for at least a month, and score 21 or higher on the MoCA. People with serious vision or hearing loss, other neurological, cardiovascular, or orthopedic conditions that affect walking, less than five years of education, vascular leg problems, or no internet access are not eligible.

## Eligibility

- **Minimum age:** 30 Years
- **Maximum age:** 75 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Diagnosed with idiopathic Parkinson's Disease
* Stage 1-3 on the Hoehn-Yahr scale
* A minimum score of 21 on the Montreal Cognitive Assessment Scale test
* Stable drug treatment within the last 1 month
* Patients are in the "On" period
* Ability to walk independently on level ground (3 and above according to Functional Ambulation Classification)

Exclusion Criteria:

* Serious hearing or vision problems
* Having other neurological, cardiovascular or orthopaedic disorders that may prevent walking
* Any other neurological disorder (e.g. dementia, cerebrovascular disease)
* less than 5 years of education
* To have vascular lower extremity pathologies
* Not having internet access via smartphone or computer
```

## Locations (1)

- Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi, Istanbul, Bakırköy, Turkey (Türkiye) _(41.0138, 28.9497)_
  - Ezgi Eryıldız — (CONTACT) — +9005071180878 — fzt.ezgigul@gmail.com

## Central Contacts

- Ezgi Gul, MSc, Pt, Research Assistant — (CONTACT) — 05071180878 — fzt.ezgigul@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT06416722*  
*HTML version: https://parkinsonspathways.com/trial/NCT06416722*  
*Source data: https://clinicaltrials.gov/study/NCT06416722*